Infectious Complications in Patients Treated With T-cell Engagers as Cancer Immunotherapies, a Descriptive Study From

Thomas Hueso1,2, Justin Cagnat1, Kaïssa Ouali1

  • 1Early Drug Development Department, Gustave Roussy  Villejuif, France.

Related Concept Videos